Patent directory · USPTO A61K / A61P
Patents matching “Vertex Pharmaceuticals Incorporated”
980 pharma patents match "Vertex Pharmaceuticals Incorporated" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 980 pharmaceutical patents matching "Vertex Pharmaceuticals Incorporated" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12421251
Cystic fibrosis transmembrane conductance regulator modulating agents
granted -
US 12421249
Inhibitors of APOL1 and methods of using same
granted -
US 12385013
Differentiation of pancreatic endocrine cells
granted -
US 12384790
Pteridinone compounds and uses thereof
granted -
US 12384762
Modulator of the Cystic Fibrosis Transmembrane Conductance Regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator
granted -
US 12377252
Implantation devices, system, and methods
granted -
US 12371665
Differentiation of pancreatic endocrine cells
granted -
US 12350262
Methods of treatment for cystic fibrosis
granted -
US 12331057
Modulators of alpha-1 antitrypsin
granted -
US 12331334
Modified urokinase-type plasminogen activator polypeptides and methods of use
granted -
US 12324802
Modulators of cystic fibrosis transmembrane conductance regulator
granted -
US 12319693
Crystalline forms of CFTR modulators
granted -
US 12304900
Islet cell manufacturing compositions and methods of use
granted -
US 12281057
Carboxamides as modulators of sodium channels
granted -
US 12269831
Modulators of cystic fibrosis transmembrane conductance regulator
granted -
US 12258333
N-(hydroxyalkyl (hetero)aryl) tetrahydrofuran carboxamides as modulators of sodium channels
granted -
US 12251387
Substituted quinoxalines and benzo[c][1,2,5]oxadiazoles as DNA-PK inhibitors
granted -
US 12247021
Substituted tetrahydrofurans as modulators of sodium channels
granted -
US 12215355
Stem cell derived islet differentiation
granted -
US 12214083
Pharmaceutical composition and administrations thereof
granted -
US 12195453
Antiproliferation compounds and uses thereof
granted -
US 12194138
Devices and methods for delivering therapeutics
granted -
US 12186306
Methods of treatment for cystic fibrosis
granted -
US 12187731
Compounds useful as inhibitors of ATR kinase
granted